Accuracy of the FAMACHA system for on-farm use by sheep and goat producers in the southeastern United States.

FAMACHA is a practical on-farm system designed to provide small ruminant producers a tool for improving their management of Haemonchus contortus infections. Although this system has become very popular and widely accepted by small ruminant producers in many regions of the southern United States, there is very limited data reported on the effectiveness of the FAMACHA system when performed by farmers. The objective of this study was to evaluate the accuracy of the FAMACHA system for on-farm use by small ruminant producers during the summer season. Small ruminant producers from Georgia, Louisiana, Florida, and Puerto Rico were trained to use the FAMACHA system by veterinarians and scientists experienced with this method. FAMACHA scores were assigned at least every 2 weeks by producers to weaned and mature sheep (n=552) and goats (n=676) of various breeds and ages between April and September 2004. At intervals that varied among farms from 2 to 8 weeks, researchers determined body condition scores (BCS; 1=thin and 5=fat) and collected blood and feces from a group of animals selected randomly to determine packed cell volume (PCV) and fecal egg counts (FEC). Two separate anemia thresholds were evaluated; these were defined by either FAMACHA score (>or=3 versus >or=4) or PCV (or=3 were considered anemic and PCV cutoff was or=3 were considered anemic and PCV cutoff was

A novel approach for combining the use of in vitro and in vivo data to measure and detect emerging moxidectin resistance in gastrointestinal nematodes of goats.

Ivermectin and moxidectin are closely related avermectin/milbemycin anthelmintics and available data suggest that side resistance occurs with these two drugs. However, moxidectin remains effective against many species of ivermectin-resistant worms due to its higher potency. The larval development assay (LDA) is routinely used to diagnose ivermectin resistance in Haemonchus contortus but laboratory diagnosis of moxidectin resistance is hampered by the lack of any validated in vitro tests. The objective of this study was to measure the relative susceptibility/resistance of H. contortus to moxidectin on goat farms in Georgia, and to validate the DrenchRite LDA for detecting resistance to moxidectin. Fecal egg count reduction tests (FECRT) were performed at five different moxidectin dose levels and DrenchRite LDAs were performed in duplicate on nine meat goat farms in Georgia, USA. To improve our ability to make inferences on the relative levels of resistance between farms, FECRT data were first analysed using a linear mixed model, and then Tukey's sequential trend test was used to evaluate the trend in response across dose levels. LDA data were analysed using log-dose logit-response and probit models. Using these statistical results, we were able to rank the nine farms from the least to the most resistant, and to develop a set of criteria for interpreting DrenchRite LDA results so that this assay can be used to diagnose both clinically apparent moxidectin resistance, as well as sub-clinical emerging resistance. These results suggest that our novel approach for examining these types of data provides a method for obtaining an increased amount of information, thus permitting a more sensitive detection of resistance. Based on results of the LDA, moxidectin-resistant farms had resistance ratios, compared with an ivermectin-sensitive farm, ranging from 32 to 128, and had resistance ratios of 6-24 compared with an ivermectin-resistant/moxidectin naive farm. Moxidectin resistance was diagnosed both in Haemonchus and Trichostrongylus on almost half of the farms tested, despite this drug only being used on these farms for 2-3 years.

Validation of the FAMACHA eye color chart for detecting clinical anemia in sheep and goats on farms in the southern United States.

Recent studies on sheep and goat farms in the southern United States indicate that multiple-anthelmintic resistance in Haemonchus contortus is becoming a severe problem. Though many factors are involved in the evolution of resistance, the proportion of the parasite population under drug selection is believed to be the single most important factor influencing how rapidly resistance develops. Therefore, where prevention of resistance is an important parallel goal of worm control, it is recommended to leave a portion of the animals untreated. Recently, a novel system called FAMACHA was developed in South Africa, which enables clinical identification of anemic sheep and goats. When H. contortus is the primary parasitic pathogen, this system can be applied on the farm level to reduce the number of treatments administered, thereby increasing the proportion of the worm population in refugia. Since most studies validating the FAMACHA method have been performed in South Africa, it is important that the method be tested in other regions before its use is broadly recommended. We performed a validation study of FAMACHA by testing the system in sheep (n = 847) and goats (n = 537) of various breeds and ages from 39 farms located in Arkansas, Georgia, Louisiana, Florida, and the US Virgin Islands. The color of the ocular conjunctiva of all animals were scored on a 1-5 scale using the FAMACHA card, and blood samples were collected from each animal for determination of packed cell volume (PCV). Fecal samples were also collected from a majority of the animals tested for performance of fecal egg counts (FEC). Correlations between PCV and eye scores, PCV and FEC, and FEC and eye scores were all highly significant for both sheep and goats (P < 0.001). Data for both FAMACHA scores and PCV were evaluated using two separate criteria for anemia: eye score values of 3, 4 and 5 or 4 and 5, and PCV values of < or =19 or < or =15 were considered anemic. Specificity was maximized when eye score values of 4 and 5 were considered anemic and PCV cut off for anemia was < or =19, but sensitivity was low. In contrast, sensitivity was 100% for both sheep and goats when eye score values of 3, 4 and 5 were considered anemic and PCV cut off was < or =15, but specificity was low. In both sheep and goats, predictive value of a negative was greater than 92% for all anemia and eye score categories, and was greater than 99% for both eye score categories when an anemia cutoff of < or =15 was used. Predictive value of a positive test was low under all criteria indicating that many non-anemic animals would be treated using this system. However, compared to conventional dosing practices where all animals are treated, a large proportion of animals would still be left untreated. These data indicate that the FAMACHA method is an extremely useful tool for identifying anemic sheep and goats in the southern US and US Virgin Islands. However, further studies are required to determine optimal strategies for incorporating FAMACHA-based selective treatment protocols into integrated nematode control programs.

Caseous lymphadenitis in small ruminants.

Caseous lymphadenitis is a contagious bacterial disease that affects sheep and goats. It is characterized by abscess formation in the skin, internal and external lymph nodes, and internal organs. The causative agent is Corynebacterium pseudotuberculosis. The disease can become endemic in a herd or flock and is difficult to eradicate by virtue of its poor response to therapeutics, its ability to persist in the environment, and the limitations in detecting subclinically affected animals. The disease causes significant economic impact on the small ruminant industry through decreased meat yield, damaged wool and leather, decreased reproductive efficiency, culling of affected animals, and mortality from the internal environment.

Surgical treatment of a septic dentigerous cyst in a goat.

A slowly growing lesion of the rostral mandible of a goat was diagnosed to be a septic dentigerous cyst. The lesion was treated surgically to remove one displaced tooth and debride the cystic cavity, and systemic antibiotic therapy was applied. Thirty-four weeks later the goat was clinically and radiographically improved and the problem had not recurred.

Lactation associated with acidophilic pituitary adenoma, pheochromocytoma, and cystic endometrial hyperplasia in two goats.

Two unbred adult female goats were examined for persistent, inappropriate lactation. Prostaglandin F2 alpha treatment was ineffective in relieving the condition. Over 5 months, 1 goat developed evidence of CNS disease; this same goat had persistently high serum prolactin concentrations. At necropsy, both goats had an acidophilic adenoma of the pars distalis, a condition that, to our knowledge, has not previously been reported in goats. In addition, both goats had pheochromocytomas and cystic endometrial hyperplasia, conditions that are rarely reported in small ruminants. The inciting cause of inappropriate lactation in goats can be difficult to determine. Pituitary adenomas should be suspected when treatment with prostaglandins is unsuccessful, signs of CNS disease develop, or persistently high serum prolactin concentrations are detected.

Biochemical changes in three-day-event horses at the beginning, middle and end of Phase C and after Phase D.

Blood samples were collected 12-16 h before the Speed and Endurance test, immediately after steeplechase, midway through Phase C (4 km marker), at the end of Phase C and immediately after cross-country from 36 horses that completed a 3-day-event at the CCI* (n = 19) or CCI** (n = 17) level. Packed cell volume (PCV), plasma concentrations of sodium, potassium, chloride, ionized calcium, pH and lactate; and serum concentrations of total protein (TP), albumin, total calcium, alkaline phosphatase (AP), gamma glutamyl transferase (GGT), creatine kinase (CK), aspartate aminotransferase (AST), glucose and creatinine were measured. No differences were noted in any biochemical measurements between the CCI* and CCI** horses at any sampling time, despite differences in speed and length of various phases of the Speed and Endurance test. For all horses (n = 36), biochemical parameters changed significantly over time (P < 0.01). The PCV, calcium, potassium, lactate, total protein and albumin concentrations were significantly increased over pre-exercise concentrations immediately after Phase B. During Phase C, these parameters decreased towards pre-exercise concentrations, thereby supporting the concept that Phase C is a recovery phase. In contrast, chloride concentration decreased, and the creatinine concentration and CK increased compared to pre-exercise concentrations from the end of Phase B to the end of Phase C. These changes probably resulted from fluid and electrolyte losses in sweat, reduced renal blood flow and continued muscular activity. Many parameters did not change significantly between the 4 km marker (midway point on Phase C) and the end of Phase C. However, there were a few notable exceptions: potassium, chloride, lactate and glucose concentrations decreased, whereas pH and creatinine concentrations increased significantly from the 4 km marker to the end of Phase C. The most significant benefit of the extra distance from the 4 km marker to the end of Phase C was that it facilitated further dissipation of lactate concentrations prior to the start of Phase D.

Heart rate response and plasma lactate concentrations of horses competing in the cross-country phase of combined training events.

The exercise intensity of horses (n = 175) competing in the cross-country phase of 4 combined training events at 5 levels of competition [novice (N), training (T), preliminary (P), intermediate (I) and advanced (A)] was investigated. Environmental conditions varied from cool and humid (mean +/- s.d. temperature and humidity = 12.1 degrees C +/- 0.6 and 88.4% +/- 8.9 RH) to moderately hot and humid (27.8 degrees C +/- 2.1 and 62.5% +/- 7.8 RH). Heart rates (beats/min) were recorded continuously at 5 s intervals with a heart monitor. Mean +/- s.d. heart rates (beats/min) for each level of competition were: 154.4 +/- 19.2 beats/min (n = 45) (N), 160.4 +/- 28.1 beats/min (n = 47) (T), 160.6 +/- 33 beats/min (n = 53) (P), 181 +/- 26.6 beats/min (n = 29) (I) and 194.6 +/- 4.2 beats/min (n = 4) (A). Plasma lactate concentration was determined at rest in a random sampling of horses (n = 36) from all competitions and within 60 s of completion of the cross-country phase in all horses. Mean +/- s.d. lactate concentration at rest was 0.98 +/- 0.3 mmol/l. Mean +/- s.d. lactate concentrations (mmol/l) of horses after exercise were: N = 8.1 +/- 7, T = 11.5 +/- 4.7, P = 17.6 +/- 6.1, I = 19 +/- 6.7 and A = 21.3 +/- 7.3. Mean plasma lactate increased significantly (P < 0.001) as levels of competition increased, although there were few significant differences in heart rate between levels. Rectal temperatures were taken immediately after completion of the cross-country phase and 10 min later. Mean +/- s.d. rectal temperatures were significantly higher 10 min after completion of the cross-country than those taken immediately after cross-country (P < 0.001). Rectal temperatures 10 min after completion of exercise were significantly higher as the level of competition increased for N through I (P < 0.001). Rectal temperatures 10 min after completion of exercise were correlated with ambient temperatures (r = 0.22, P = 0.01). There was no significant correlation between either pulse or respiratory rate taken immediately after completion of exercise with heart rate during the course.

Heart rate response and plasma lactate concentrations of horses competing in the speed and endurance phase of 3-day combined training events.

The exercise intensity of horses competing in 3-day combined training events at 3 different levels of competition (CCI, n = 7; CCI, n = 11; CCI, n = 23) was investigated. Environmental conditions during all events were cool with 100% cloud cover. Heart rates were continuously recorded at 5 s intervals by a heart rate monitor. Mean +/- s.d. heart rate for all horses during each phase were: Phase A = 118 +/- 11 beats/min, Phase B = 179 +/- 22.7 beats/min, Phase C = 129 +/- 13.9 beats/min and Phase D = 174 +/- 19.6 beats/min. Mean +/- s.d. heart rates on Phase A and C were significantly different from mean heart rates on Phases B and D. Plasma lactate concentrations were determined at rest, within 60 s and 10 min after the end of Phase D or the cross country test. Mean +/- s.d. lactate concentrations were highest immediately post exercise (mean = 18.4 +/- 5 mmol/l for all horses) and had declined significantly in 10 min (mean = 15 +/- 6.8 mmol/l for all horses). Mean +/- s.d. heart rates and lactate concentrations were not significantly different among levels of competition at each time period. The intensity of work of fit horses successfully competing in 3-day combined training events consists of both low intensity aerobic exercise and more intense submaximal work with significant anaerobiosis. The work intensity is remarkably constant throughout different levels of competition, despite the increasing distance, number and difficulty of jumping efforts and faster optimum speeds.

Haematological and biochemical changes in horses competing in a 3 Star horse trial and 3-day-event.

Haematological and biochemical changes in horses competing in the Endurance Test (Phase T and D) of an advanced Horse Trial (HT, n = 22) and the Endurance Test (Phases A-D) of an advanced (CCI) 3-day-event (TD, n = 11) over a similar course on the same day were studied. Environmental conditions during the event were cool (5.5-11.1 degrees C). Blood samples were collected from the horses in each group the evening prior to the Endurance Test, within 60 s after, and 10 min after, completion of Phase D (cross-country jumping). The following were determined in the blood samples and compared between the 2 groups of horses: packed cell volume (PCV), serum total protein [TP], serum albumin [ALB], plasma lactate [lactate], serum total calcium [TCa], plasma ionised calcium [Ca+2], serum inorganic phosphate [PO4], plasma pH, plasma sodium [Na], plasma potassium [K], serum chloride [Cl], serum urea nitrogen [SUN], serum creatinine [Cr] and serum glucose concentrations and aspartate aminotransferase (AST) and creatine kinase (CK) activities. The PCV and [Cr] were higher in the TD group and approached significance (P = 0.063 and P = 0.057, respectively). The [TP], [ALB], [Na], glucose concentration and CK, and AST were significantly higher and [Cl] and [PO4] were significantly lower in the TD group after exercise when compared to the HT group. It was deduced from these data that the horses competing in the 3-day-event experienced greater fluid and electrolyte losses, reduced glomerular filtration, higher glycogenolysis and had greater leakage of enzymes from working muscles during competition than horses competing in the horse trial.

Effects of shortening the steeplechase phase (phase B) of a 3-day-event.

Thirty-four horses competing in the Endurance Test of a 3-day-event were divided into 3 groups: horses in Group 1 (n = 15) competing in a 3.5 min steeplechase phase; horses in Group 2 (n = 13) in a 3 min steeplechase phase (Phase B) and horses in Group 3 (n = 6) in a 2.5 min steeplechase phase. The shortening of Phase B was associated with a lengthening of Phase C so that the total distance of the event for all horses was 14,940 m. Bodyweight (BW) was measured and total body water (TBW) and water loss estimated. Blood samples were collected from the horses prior to the Endurance Test, at the end of Phase B, the 4 km marker on Phase C (C4K), the end of Phase C, and 20 min after the completion of Phase D for measurement of packed cell volume (PCV), total plasma protein [TPP], lactate, ionised calcium, pH, sodium, potassium, chloride, total calcium and glucose concentrations, and aspartate aminotransferase, creatine kinase and lactate dehydrogenase activities. Mean +/- s.d. ambient environmental temperature during the Endurance Test was 25.3 +/- 1 degrees C (range 20.3 degrees C-29.7 degrees C). Mean relative humidity was 43.8 +/- 2.4% (range 39%-48.6%) and the average 'comfort index' (CI) was 121. There were no significant differences between the groups competing in the Endurance Test, despite the shorter Phase B. However, there were significant decreases in BW, TBW, net exchangeable cations, chloride, ionised calcium, and pH. The sodium and total calcium concentrations remained at near pre-event values. The PCV, TPP, lactate, potassium, glucose, aspartate aminotransferase, and lactate dehydrogenase activity increased during the Endurance Test, when compared to pre-event values. Horses competing in this competition experienced significant fluid and electrolyte losses, reduced glomerular filtration, increased glycogenolysis and had significant leakage of enzymes from working muscles during competition. These changes could not be reduced by shortening Phase B and lengthening Phase C.

Acid:base and serum biochemistry changes in horses competing at a modified 1 Star 3-day-event.

We examined the effects of participation in each of 3 modifications of Day 2 of a 3-day-event on blood and serum variables indicative of hydration, acid:base status and electrolyte homeostasis of horses. Three groups of horses - 8 European (E) horses and 2 groups each of 9 North American horses performed identical Days 1 (dressage) and 3 (stadium jumping) of a 3-day-event. E horses and one group of the North American horses (TD) performed modifications of Day 2 of a 1 Star 3-day-event and the other group of North American horses (HT) performed a Horse Trial on Day 2. Jugular venous blood was collected from each horse on the morning of Day 2 before any warm-up activity, between 4 min 55 s and 5 min 15 s after Phase D and the following morning. Eight E horses, 5 TD horses and 8 HT horses completed the trials. There were few significant differences in acid:base or serum biochemistry variables detected among horses performing either 2 variations of the Speed and Endurance day of a 1 Star 3-day-event, or a conventional Horse Trial. Failure to detect differences among groups may have been related to the low statistical power associated with the small number of horses, especially in the TD group, variation in quality of horses among groups and the different times of the day at which the E horses competed. Differences detected among time points were usually common to all groups and demonstrated metabolic acidosis with a compensatory respiratory alkalosis, a reduction in total body water and cation content, and hypocalcaemia. Importantly, horses of all groups did not replenish cation, chloride, and calcium deficits after 14-18 h of recovery.

Physiological responses of horses competing at a modified 1 star 3-day-event.

The impending 1996 summer Olympic 3-day-event in Atlanta has focused attention on the need to determine what modifications to the demanding Endurance Test will be required to ensure safety of the horses competing. Three groups of horses participated in a Field Trial held in August of 1994 in northern Georgia to determine the safety and feasibility of conducting a modified 3-day-event in hot, humid weather. One group (TD) completed a modified 1 Star 3-day-event test, a control group (HT) completed a Horse Trial identical to the modified 1 Star test except for the omission of Phases B and C and the third group (E), comprised of European horses, completed the modified 1 Star test with a longer, faster Phase C than was used for TD. During the Endurance Test, the ambient temperature and relative humidity ranged from 24.3 degrees C and 98.9% in the morning to 30.2 degrees C and 51.6% in the afternoon. No horse failed to complete the Trial because of heat stress or fatigue. There were no significant (P < 0.05) differences detected in heart rate, rectal temperature, respiratory rate or net weight loss between HT and TD horses at any observation time. The highest rectal temperature recorded at the end of Phase C was 39.6 degrees C. These findings suggest that the modified 1 Star Endurance Test was as well tolerated by American horses as the control Horse Trial test. Rectal temperature was significantly higher for E than for TD or HT at the finish of Phase C. European horses had significantly greater decreases in weight than HT and TD at the end of Phases C and D and the next day. These findings probably reflect the faster and longer work effort of E horses during Phase C. Modification of Phase C and the rest-pause to ensure that recovery and heat dissipation occurred before the start of Phase D resulted in a 3-day-event that was safe for horses. The Field Trial provides a model for designing a modified Olympic Endurance Test. If the 1996 Olympic 3-day-event is held in hotter and more humid weather than the Field Trial, additional modifications to the Endurance Test (decreased distances, speeds and numbers of jumping efforts) will probably be required to ensure safety of competing horses.

Weight, water, and cation losses in horses competing in a three-day event.

Body weight of 48 horses competing in a 3-day event was measured the day before the event (baseline), following the dressage phase of the event (day 1), after the endurance phases of the event (day 2), and 18 to 24 hours after the endurance phases (day 3). Plasma sodium and potassium concentrations were measured the evening before, immediately after, and 10 minutes after the endurance phases. Total body water, water loss, and net exchangeable cation loss were then calculated. Body weight and total body water were significantly decreased, compared with baseline values, at all times during the event, and significant water loss was detected. The largest changes were recorded after the endurance phases of the event. Water deficits were still detected 18 to 24 hours after the endurance phases of the event. Mean plasma sodium concentration was significantly increased immediately after the endurance phases of the event, compared with concentration measured the evening before, and remained increased after the 10-minute recovery period, presumably because of dehydration. Mean plasma potassium concentration was significantly increased immediately after the endurance phases of the event, compared with concentration measured the evening before, but was not increased after the 10-minute recovery period.

Intracranial schwannoma in a horse.

A case of intracranial schwannoma is described in a young horse. Clinical signs developed slowly and were suggestive of a lesion involving the left cerebrum. The filly exhibited a change in mentation, and circled to the left. Visual impairment and decreased facial sensation were noted on the right side. A solitary schwannoma which compressed the left cerebrum was found at necropsy.

Platelet collection with the Autopheresis-C apheresis system.

This report describes a new system for collection of platelet concentrate (PC) and cell-free plasma (PPP) from apheresis donors. The system uses two separation devices and requires only a single venipuncture. The Plateletcell device separates primary platelet concentrate (PPC) from anticoagulated whole blood and the Plasmacell-C device separates the PPC into PC and PPP. Results of functional studies performed indicate that the separation process does not alter viability of either the PPC, the PC, or the PPP. Platelet function after 5 days of storage is maintained. An average yield of 3.4 +/- 0.7 x 10(11) platelets in 201 g of PC and 422 g of PPP were harvested in 71 +/- 13 min of donor time from donors with preprocedure hematocrits averaging 42.5 +/- 2.0% and preprocedure platelet counts averaging 265 +/- 61 x 10(3)/microliters.